Well said Joel. Clearly bid doesn’t understand the intent of your post.
With this company it’s foolish to ignore the past with the consistent misinformation they have published.
CM is the only new face amongst a board of directors who have overseen the past misinformation so it’s only prudent to be aware of that past.
I am certainly giving our new CEO the benefit of the doubt at this stage but blind faith no way.
- Forums
- ASX - By Stock
- SPL
- Ann: DEP outperforms leading treatments in ovarian cancer model
Ann: DEP outperforms leading treatments in ovarian cancer model, page-15
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 9.7¢ | $111.3K | 1.115M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 43696 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 130967 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 0.098 |
2 | 43696 | 0.097 |
3 | 86904 | 0.095 |
1 | 100000 | 0.093 |
1 | 50000 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 530 | 1 |
0.105 | 143467 | 2 |
0.110 | 241580 | 6 |
0.115 | 109827 | 3 |
0.120 | 63057 | 7 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |